Trial intelligence / Profile preview

Perioperative erythropoietin in primary total hip arthroplasty

ChiCTR2000039970Phase 4Recruiting

Sponsor
The Affiliated Hospital of Xuzhou Medical University
Start
Dec 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of erythropoietin in osteoarthritis (OA) and osteonecrosis of the hip (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: weight. Started Dec 2020; status: recruiting.

02

Drugs

erythropoietin
03

Conditions

osteoarthritis (OA)osteonecrosis of the hip

Beyond the preview

Go deeper on ChiCTR2000039970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call